DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats

Intensive Care Medicine

Volumn 32, Issue 8, 2006, Pages 1263-1270

  Li, Yan ^a   Li, Xuemei ^a   Haley, Michael ^a   Fitz, Yvonne ^a   Gerstenberger, Eric ^a   Banks, Steven M ^a   Eichacker, Peter Q ^a   Cui, Xizhong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

DTPA Fe(III); Nitric oxide inhibition; Sepsis; Septic shock; Treatment

Indexed keywords

CYTOKINE; FERRIC ION; INTERLEUKIN 1; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTETIC ACID DERIVATIVE; PENTETIC ACID IRON COMPLEX; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTERY CATHETERIZATION; ARTICLE; BACTERIAL COUNT; CATHETER INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; HYPOTENSION; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SEPSIS; TREATMENT OUTCOME; VEIN CATHETERIZATION;

ANIMALS; CYTOKINES; ESCHERICHIA COLI INFECTIONS; FERRIC COMPOUNDS; HYPOTENSION; MALE; PENTETIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SURVIVAL RATE;

EID: 33747186373     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0234-2     Document Type: Article

References (38)

1. Cobb JP, Danner RL (1996) Nitric oxide and septic shock. JAMA 275:1192-1196
2. Kengatharan KM, De Kimpe SJ, Thiemermann C (1996) Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol 119:1411-1421
3. Farias NC, Borelli-Montigny GL, Fauaz G, Feres T, Borges AC, Paiva TB (2002) Different mechanism of LPS-induced vasodilation in resistance and conductance arteries from SHR and normotensive rats. Br J Pharmacol 137:213-220
4. Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595
5. Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF (1990) Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132-1138
6. Molina L, Studenberg S, Wolberg G, Kazmierski W, Wilson J, Tadepalli A, Chang AC, Kosanke S, Hinshaw L (1996) Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli. J Clin Invest 98:192-198
7. Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA, Solomon MA, Elin RJ, Hosseini JM, Danner RL (1992) N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182
8. Cobb JP, Natanson C, Quezado ZM, Hoffman WD, Koev CA, Banks S, Correa R, Levi R, Elin RJ, Hosseini JM, Danner RL (1995) Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 268:H1634-1642
9. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30
10. Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57
11. Babu BR, Griffith OW (1998) Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol 2:491-500
12. Kazmierski WM, Wolberg G, Wilson JG, Smith SR, Williams DS, Thorp HH, Molina L (1996) Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock. Proc Natl Acad Sci U S A 93:9138-9141
13. Li Y, Molina L, Solomon S, Fitz Y, Danner RL, Natanson C, Eichacker PQ, Cui X (2004) Iron (III) complex of diethylenetraimine pentaacetic acid [DTPA Fe(III)] decreased nitrate/nitrite levels and increased blood pressure but not survival during E. coli sepsis in rats. Am J Respir Crit Care Med 169:A632
14. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
15. Freeman BD, Correa R, Karzai W, Natanson C, Patterson M, Banks S, Fitz Y, Danner RL, Wilson L, Eichacker PQ (1996) Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J Appl Physiol 80:2066-2076
16. Yang BK, Vivas EX, Reiter CD, Gladwin MT (2003) Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 37:1-10
17. Cui X, Parent C, Macarthur H, Ochs SD, Gerstenberg E, Solomon S, Fitz Y, Danner RL, Banks SM, Natanson C, Salvemini D, Eichacker PQ (2004) Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. J Appl Physiol 97:1349-1357
18. Rahhal S, Richter HW (1989) Reaction of hydroxyl radicals with the ferrous and ferric iron chelates of diethylenetriamine-N,N,N′,N″, N″-pentaacetate. Free Radic Res Commun 6:369-377
19. Pasternack R, Halliwell B (1979) Superoxide dismutase activities of an iron porphyrin and other iron complexes. J Am Chem Soc 101:1026-1031
20. Albuszies G, Bruckner UB (2003) Antioxidant therapy in sepsis. Intensive Care Med 29:1632-1636
21. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D (2000) Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 97:9753-9758
22. Macarthur H, Couri DM, Wilken GH, Westfall TC, Lechner AJ, Matuschak GM, Chen Z, Salvemini D (2003) Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Crit Care Med 31:237-245
23. Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321S-329S
24. Bogdan C, Rollinghoff M, Diefenbach A (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12:64-76
25. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 192:227-236
26. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE, Dougan G (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192:227-236
27. Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM (2000) Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 68:3587-3593
28. Miyagi K, Kawakami K, Saito A (1997) Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun 65:4108-4113
29. Mastroeni P, Skepper JN, Hormaeche CE (1995) Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 63:3674-3682
30. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S (1991) Divergent efficacy of antibody to TNF in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88
31. Echtenacher B, Falk W, Mannel DN, Krammer PH (1990) Requirement of endogenous tumor necrosis factor/cachetin for recovery from experimental peritonitis. J Immunol 145:3762-3766
32. Haley M, Parent C, Cui X, Kalil A, Fitz Y, Correa-Araujo R, Natanson C, Danner RL, Banks SM, Eichacker PQ (2005) Neutrophil inhibition with L-selectin directed mAb improves or worsens survival dependent upon the route but not severity of infection in a rat sepsis model. J Appl Physiol 98:2155-2162
33. Kim YM, Hong SJ, Billiar TR, Simmons RL (1996) Counterprotective effect of erythrocytes in experimental bacterial peritonitis is due to scavenging of nitric oxide and reactive oxygen intermediates. Infect Immun 64:3074-3080
34. Umezawa K, Akaike T, Fujii S, Suga M, Setoguchi K, Ozawa A, Maeda H (1997) Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect Immun 65:2932-2940
35. Cohen RI, Shapir Y, Chen L, Scharf SM (1998) Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med 26:738-747
36. Henderson JL, Statman R, Cunningham JN, Cheng W, Damiani P, Siconolfi A, Horovitz JH (1994) The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia. Arch Surg 129:1271-1274
37. Dahm PL, Thorne J, Myhre E, Grins E, Martensson L, Blomquist S (1999) Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition. Acta Anaesthesiol Scand 43:56-63
38. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197-1205